JPHC CE: Urine Drug Screening: What Pediatric Clinicians Need to Know to Optimize Patient Care

0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents,UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).

Important: You must be logged in to use your NAPNAP Member ID# and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright © 2021 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved. 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hours of which 0.5 contain pharmacology content and 0.5 controlled substances. 

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

1. State the differences of the most common urine drug screening testing modalities: immunoassay and gas chromatography/mass spectrometry.
2. Describe common causes of false-positive and false-negative urine drug testing results and the detection window of specific medications.
3. Identify common caveats when interpreting urine drug testing result.
 

Course summary
Available credit: 
  • 0.50 Contact hours
Course opens: 
06/30/2021
Course expires: 
08/31/2022
Cost:
$10.00
Rating: 
0

Logan Johnson Doriety, Post Graduate Year - 2 Pharmacist Resident, Department of Pharmacy, New Hanover Regional Medical Center, Wilmington, NC.
Elizabeth Anne Farrington, Clinical Pharmacist, Pediatrics, Department of Pharmacy, New Hanover Regional Medical Center, Wilmington, NC.

Conflicts of interest: None to report.

Correspondence:

Elizabeth Anne Farrington, PharmD, FCCP, FCCM, FPPA, BCPS, BCNSP, Department of Pharmacy, New
Hanover Regional Medical Center, 2131 S 17th St., PO Box 9000, Wilmington, NC 28402-9000

e-mail: Elizabeth.Farrington@nhrmc.org.

 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hours of which 0.5 contain pharmacology content and 0.5 controlled substances. 

Available Credit

  • 0.50 Contact hours

Price

Cost:
$10.00
Please login or register to take this course.